INHIBITORY-ACTION OF PPADS ON RELAXANT RESPONSES TO ADENINE-NUCLEOTIDES OR ELECTRICAL-FIELD STIMULATION IN GUINEA-PIG TAENIA-COLI AND RAT DUODENUM

被引:73
作者
WINDSCHEIF, U
PFAFF, O
ZIGANSHIN, AU
HOYLE, CHV
BAUMERT, HG
MUTSCHLER, E
BURNSTOCK, G
LAMBRECHT, G
机构
[1] UNIV FRANKFURT,BIOCTR NIEDERURSEL,DEPT BIOCHEM,D-60439 FRANKFURT,GERMANY
[2] UNIV LONDON UNIV COLL,DEPT ANAT & DEV BIOL,LONDON WC1E 6BT,ENGLAND
[3] UNIV LONDON UNIV COLL,CTR NEUROSCI,LONDON WC1E 6BT,ENGLAND
[4] UNIV FRANKFURT,BIOCTR NIEDERURSEL,DEPT BIOCHEM,D-60439 FRANKFURT,GERMANY
[5] KAZAN MED INST,KAZAN 420012,RUSSIA
基金
英国惠康基金;
关键词
PPADS; 2-METHYLTHIO ATP; ATP; ALPHA; BETA-METHYLENE ATP; CARBACHOL; P-2Y-PURINOCEPTOR; ELECTRICAL FIELD STIMULATION; ECTONUCLEOTIDASE; GUINEA-PIG TAENIA COLI; RAT DUODENUM;
D O I
10.1111/j.1476-5381.1995.tb16644.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of pyridoxalphosphate-6-azophenyl-2,4'-disulphonic acid (PPADS) on the relaxant response to adenine nucleotides was examined in the carbachol-contracted guinea-pig taenia coli and rat duodenum, two tissues possessing P-2y-purinoceptors. In addition, in the taenia coli PPADS was investigated for its effect on relaxations evoked by adenosine, noradrenaline and electrical field stimulation. In order to assess the selectivity of PPADS between P-2-purinoceptor blockade and ecto-nucleotidase activity, its influence on ATP degradation was studied in guinea-pig taenia coli. 2 The resulting rank order of potency for the adenine nucleotides in guinea-pig taenia coli was: 2-methylthio ATP> > ATP > alpha,beta-methylene ATP with the respective pD(2)-values 7.96 +/- 0.08 (n = 23), 6.27 +/- 0.12 (n = 21) and 5.88 +/- 0.04 (n = 24). 3 In guinea-pig taenia coli, PPADS (10-100 mu M) caused a consistent dextral shift of the concentration-response curve (CRC) of 2-methylthio ATP and ATP resulting in a biphasic Schild plot. A substantial shift was only observed at 100 mu M PPADS, the respective pA(2)-values at this particular concentration were 5.26 +/- 0.16 (n = 5) and 5.15 +/- 0.13 (n = 6). Lower concentrations of PPADS (3 - 30 mu M) antagonized the relaxant effects to alpha,beta-methylene ATP in a surmountable manner. An extensive shift of the CRC was produced only by 30 mu M PPADS (pA(2) = 5.97 +/- 0.08, n = 6), and the Schild plot was again biphasic. 4 The relaxant responses to electrical field stimulation (80 V, 0.3 ms, 5 s, 0.5-16 Hz) in guinea-pig taenia coli were concentration-dependently inhibited by PPADS (10-100 mu M). 5 In guinea-pig taenia coli, the potency of ATP in inducing relaxation appeared to be independent of its rate of degradation by ecto-nucleotidases, since the K-m-value (366 mu M) obtained in the enzyme assay was much higher than the functional EC(50)-value (0.45 mu M) of ATP. PPADS (3-100 mu M) was only weakly active in inhibiting ecto-nucleotidase activity leaving a residual activity of 81.8 +/- 5.1% at 100 mu M. Enzyme inhibition by PPADS was concentration-independent and non-competitive, 6 In rat duodenum, the rank order of potency was: 2-methylthio ATP > ATP > > alpha,beta-methylene ATP, the respective pD(2)-values being 6.98 +/- 0.04 (n = 76), 6.26 +/- 0.02 (n = 6) and 4.83 +/- 0.02 (n = 6). Among these agonists, 2-methylthio ATP displayed the lowest apparent efficacy. 7 The CRC of 2-methylthio ATP in rat duodenum was shifted to the right by PPADS (10-100 mu M) in a concentration-dependent manner, and Schild analysis gave a pA(2)-value of 5.09 +/- 0.06 (slope = 1.02, n = 14). 8 PPADS was without any effect on the carbachol-induced contraction in guinea-pig taenia coli or rat duodenum and on the relaxation to noradrenaline or adenosine in guinea-pig taenia coli. 9 In conclusion, the antagonistic properties of PPADS at the taenia coli and rat duodenum P-2y-purinoceptors were different from those recently described at the P-2x-subtype: inhibition of P-2y-purinoceptor-mediated responses was observed at higher concentrations (3-100 mu M vs. 1-10 (30) mu M Furthermore, we conclude that in addition to the classical P-2y-subtype, which is largely PPADS-resistant, the guinea-pig taenia coli may be endowed with a distinct relaxation-mediating P-2-purinoceptor subtype which is sensitive to PPADS.
引用
收藏
页码:1509 / 1517
页数:9
相关论文
共 53 条
[41]   THE USE OF ANTAGONISTS TO CHARACTERIZE THE RECEPTORS MEDIATING DEPOLARIZATION OF THE RAT ISOLATED VAGUS NERVE BY ALPHA,BETA-METHYLENE ADENOSINE 5'-TRIPHOSPHATE [J].
TREZISE, DJ ;
KENNEDY, I ;
HUMPHREY, PPA .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (01) :282-288
[42]   P-2 PURINOCEPTOR ANTAGONIST PROPERTIES OF PYRIDOXAL-5-PHOSPHATE [J].
TREZISE, DJ ;
BELL, NJ ;
KHAKH, BS ;
MICHEL, AD ;
HUMPHREY, PPA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 259 (03) :295-300
[43]   NEW CLASS OF LIGAND-GATED ION-CHANNEL DEFINED BY P-2X RECEPTOR FOR EXTRACELLULAR ATP [J].
VALERA, S ;
HUSSY, N ;
EVANS, RJ ;
ADAMI, N ;
NORTH, RA ;
SURPRENANT, A ;
BUELL, G .
NATURE, 1994, 371 (6497) :516-519
[44]   CLONING AND FUNCTIONAL EXPRESSION OF A BRAIN G-PROTEIN-COUPLED ATP RECEPTOR [J].
WEBB, TE ;
SIMON, J ;
KRISHEK, BJ ;
BATESON, AN ;
SMART, TG ;
KING, BF ;
BURNSTOCK, G ;
BARNARD, EA .
FEBS LETTERS, 1993, 324 (02) :219-225
[45]   ATP ANALOGS AND THE GUINEA-PIG TAENIA-COLI - A COMPARISON OF THE STRUCTURE-ACTIVITY-RELATIONSHIPS OF ECTONUCLEOTIDASES WITH THOSE OF THE P-2-PURINOCEPTOR [J].
WELFORD, LA ;
CUSACK, NJ ;
HOURANI, SMO .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 129 (03) :217-224
[46]  
WILKINSON GF, 1994, J PHARMACOL EXP THER, V268, P881
[47]   VASOCONSTRICTOR AND VASODILATOR RESPONSES TO VARIOUS AGONISTS IN THE RAT PERFUSED MESENTERIC ARTERIAL BED - SELECTIVE-INHIBITION BY PPADS OF CONTRACTIONS MEDIATED VIA P-2X-PURINOCEPTORS [J].
WINDSCHEIF, U ;
RALEVIC, V ;
BAUMERT, HG ;
MUTSCHLER, E ;
LAMBRECHT, G ;
BURNSTOCK, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (03) :1015-1021
[48]  
WINDSCHEIF U, 1994, IN PRESS ARZNEIM FOR
[49]  
WINDSCHEIF U, 1994, DRUG DEVELOP RES, V31, P334
[50]   SELECTIVE ANTAGONISM BY PPADS AT P-2X-PURINOCEPTORS IN RABBIT ISOLATED BLOOD-VESSELS [J].
ZIGANSHIN, AU ;
HOYLE, CHV ;
LAMBRECHT, G ;
MUTSCHLER, E ;
BAUMERT, HG ;
BURNSTOCK, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 (03) :923-929